Pharmacovigilance Learning Pathway

 Pharmacovigilance Regulatory Timelines Explained: Day 0, Day 7, Day 15, and Day 90 Reporting Pharmacovigilance regulatory timelines define how quickly adverse drug reactions must be reported to health authorities after they are identified. These timelines ensure that important safety information about medicines is communicated promptly, allowing regulators to assess risks and protect patient safety. In pharmacovigilance, reporting timelines are calculated from Day 0, which is the date when a valid Individual Case Safety Report (ICSR) is first received by the pharmacovigilance system. The most common reporting milestones include Day 7, Day 15, and Day 90.

  ICSR Processing in Pharmacovigilance: Step-by-Step Workflow for Beginners Introduction Pharmacovigilance focuses on the continuous monitoring of medicine safety in real-world use. One of the core activities in this field is the processing of Individual Case Safety Reports (ICSRs). An ICSR contains information about a suspected adverse drug reaction reported by a patient, healthcare professional, or other credible source, and it helps identify potential safety concerns related to medicinal products. ICSR processing involves a sequence of clearly defined steps, starting from the receipt of a case and continuing through data verification, medical assessment, regulatory reporting, and follow-up. Each step must be completed accurately and within regulatory timelines to ensure compliance and to support patient safety . In this blog, the ICSR processing workflow is explained in a step-by-step manner, highlighting how safety cases are handled in routine pharmacovigilance pract...

Adverse Drug Reactions( ADR): Types, Minimum Criteria for ICSR, and Challenge-Dechallenge-Rechallenge Explained Introduction Adverse Drug Reactions (ADRs) are a central concept in pharmacovigilance because they directly affect patient safety and regulatory decision-making throughout the lifecycle of a medicinal product. Identifying, evaluating, and reporting ADRs helps healthcare professionals and regulatory authorities detect potential drug safety issues. This article explains the different types of ADRs, the four minimum criteria required for a valid Individual Case Safety Report (ICSR), and the concepts of challenge, dechallenge, and rechallenge used in causality assessment. What is an Adverse Drug Reaction (ADR)? An Adverse Drug Reaction (ADR) is a harmful and unintended response to a medicinal product for which a causal relationship between the drug and the event is suspected. To understand the basic pharmacovigilance terminology used in drug safety, read our guide on Key Terminol...

 Key Terminologies in Pharmacovigilance Explained (ADR, AE, SAE, SUSAR, ICSR Guide) Pharmacovigilance involves monitoring the safety of medicines and identifying adverse effects associated with drug use. To understand drug safety reporting, it is important to learn the key pharmacovigilance terminologies used in clinical trials and post-marketing surveillance. In this guide, we explain important pharmacovigilance terms such as Adverse Event (AE), Adverse Drug Reaction (ADR), Serious Adverse Event (SAE), SUSAR, ICSR, signal detection, and risk management with practical examples for beginners.

Introduction to Pharmacovigilance (PV): Definition, History and  Key Concepts for Beginners Introduction  Pharmacovigilance (PV) is an essential discipline in healthcare that focuses on ensuring the safety of medicines. Since no drug is completely free from risk, continuous monitoring is required to detect and prevent adverse effects and to protect patients and public health.  This blog explains the basic concepts of Pharmacovigilance, including its definition, objectives, scope, types, and historical background. It is especially useful for students, freshers, and beginners in Pharmacovigilance. To make it easier, watch this short video explaining the basics of pharmacovigilance in a clear and simple way. What is Pharmacovigilance?  Pharmacovigilance is a medical profession and scientific discipline that involves activities aimed at promoting and safeguarding patient safety and public health.  According to the World Health Organization (WHO), Pharmacovigilance ...